Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. People
    3. Hannah BornsteinPeople
    1. Home
    2. People
    3. Hannah BornsteinPeople

    Hannah Bornstein

    Partner / Deputy Practice Group Leader, Government Investigations & White Collar Defense


    • Boston
    • Office617.345.1217
    • hbornstein@nixonpeabody.com
    • Download vCard
    • Share

    Introduction

    Hannah Bornstein is a litigator, trusted advisor, and the deputy practice group leader for Government Investigations & White Collar Defense. She is also a member of the firm’s Life Sciences team. She represents individuals and multi-national companies in regulatory compliance matters, investigations, and litigation. She is experienced in healthcare industry matters involving the False Claims Act; the Food, Drug and Cosmetic Act (FDA); and the Anti-Kickback Statute.

    Practice Areas

    Government Investigations & White Collar DefenseLitigationFalse Claims Act & Qui Tam MattersGlobal Compliance & InvestigationsLife Sciences & Healthcare Compliance and InvestigationsLife SciencesCongressional InvestigationsState Attorneys General

    Industries

    Arts & Cultural InstitutionsHealthcareConsumer

    My focus

    I counsel life sciences companies through a range of FDA compliance, enforcement, and litigation matters. Whether assessing a potential product approval pathway, conducting due diligence in a transaction, or responding to a government investigation, I help clients navigate myriad complex government regulations and oversight.

    I represent clients in high-stakes crisis matters, including responding to government inquiries or investigations conducted by the FDA, the United States Attorney’s Office, and the Department of Justice, among others. I bring my experience in enforcement matters to my clients’ compliance and transactional matters, helping them anticipate—and avoid—potential pitfalls.

    Government Investigations and Related Litigation

    I represent multi-national companies, including pharmaceutical and medical device companies, in responding to governmental inquiries or investigations conducted by the United States Attorney’s Office and the Department of Justice, among others. I have advised companies in responding to grand jury subpoenas, HIPAA subpoenas, and civil investigative demands (CIDs), as well as informal requests for information. In instances where the government declines to intervene in an investigation, I represent companies in subsequent litigation that is driven by the whistleblowers or relators. I also represent numerous individuals, who are often current or former employees of a company, in connection with government investigations.

    I also represent companies in matters initiated by the Massachusetts Attorney General’s Office involving False Claims Act investigations or Consumer Protection Act (“Chapter 93A”) litigation.

    Regulatory and Compliance Matters

    I guide companies through a wide range of regulatory and compliance matters, including questions relating to product approval pathways, promotion and advertising, and overall regulatory and agency strategy. I work with clients in a variety of areas, including the digital health, in vitro diagnostics (IVDs), dietary supplements, CBD, pharmaceutical, and medical device spaces.

    Transactional Due Diligence

    I work with our transactional deal teams in providing advice and analysis on FDA-related due diligence matters. My work in this space includes the pharmaceutical, digital health, medical device, and food areas.

    Representative experience

    Hannah’s representative matters have involved government inquiries relating to possible “off-label” promotion and whether a drug or device was marketed in accordance with its approved intended use; possible false or misleading advertising; compliance with the Anti-Kickback Statute; and compliance with CGMP standards, including investigations that follow FDA 483 warning letters. Her representative matters include the following:

    • Represent medical device company in False Claims Act investigation and litigation regarding manufacture and sale of medical device
    • Represent pharmaceutical manufacturer in novel FDA enforcement matter, and advise client on navigating complex government, customer, and media concerns
    • Represent investors in connection with FDA due diligence reviews regarding potential investment in FDA-regulated pharmaceutical, medical device, health technology, and food companies
    • Provide compliance advice to a range of life sciences companies on a variety of FDA compliance and approval pathway questions, including areas related to digital health, diagnostics and laboratory-developed tests, dietary supplements, COVID-19 products, and promotion questions
    • Represented pharmaceutical company in defense of a United States Attorney’s Office investigation regarding company’s manufacturing practices and CGMP compliance
    • Represent pharmaceutical company in defense of a United States Attorney’s Office investigation regarding company’s compliance with manufacturing and compliance procedures
    • Represent various pharmaceutical companies in matters involving compliance with the Anti-Kickback Statute
    • Represent senior executives and managers of medical device company in defense of a United States Attorney’s Office investigation of possible violations of the Food, Drug & Cosmetic Act
    • Represent physician advisors of medical device company in defense of a United States Attorney’s Office investigation of possible violations of the Food, Drug & Cosmetic Act
    • Provide advice to physician client regarding marketing and labeling claims
    • Represented pharmaceutical company in Consumer Protection Act litigation brought by Massachusetts Attorney General’s Office
    • Represented pharmaceutical company in defense of a United States Attorney’s Office investigation into alleged off-label promotion and kickback activity in connection with company’s contractual relationships with specialty pharmacy companies
    • Represented public company in False Claims Act investigation brought by Massachusetts Attorney General’s Office
    • Represented pharmaceutical company in defense of a United States Attorney’s Office investigation into alleged off-label promotion
    • Represented pharmaceutical company in defense of a United States Attorney’s Office investigation into alleged kickback activity in connection with company’s grant-making processes
    • Represented medical device company in defense of a United States Attorney’s Office investigation into alleged kickback activity in connection with company’s contractual relationships with customers
    • Represented former senior executive of a pharmaceutical company in defense of a United States Attorney’s Office investigation into alleged kickback activity in connection with pricing and discounting practices
    • Represented retailer in connection with an SEC investigation relating to the company’s accounting practices

    Looking ahead

    Innovation is fast outpacing the legal and regulatory framework in many areas, particularly in areas such as digital health and CBD. In areas where the applicable legal and regulatory framework is unclear and not well-developed, companies are well-advised to seek counsel early in their decision-making processes in order to make their best, good-faith assessments on how to proceed. A demonstrated commitment to compliance will pay dividends as companies grow and mature.

    Insights

    • “Negotiating False Claims Act Settlements,” in Health Law Handbook, Thomson Reuters, 2021 (co-author)

    In the news

    • Medtech Insight

      Ex-Theranos CEO Elizabeth Holmes sentenced to 11-year prison term

      Boston partner Hannah Bornstein, deputy leader of the firm’s Government Investigations & White-Collar Defense practice, provides third-party commentary throughout this article on the sentencing of former Theranos CEO Elizabeth Holmes. Hannah discusses the significance of Holmes’ sentence and the potential impact of the Theranos case on the life sciences and venture capital industries.

      Nov 23, 2022
    • Law360

      Holmes faces uphill battle fighting 11-year prison term

      This article, which follows up on ex-Theranos CEO Elizabeth Holmes’ sentencing, quotes from a related client alert written by Boston Government Investigations and White-Collar Defense partners Brian French and Hannah Bornstein, deputy leader of the practice group.

      Nov 21, 2022
    • Pratt’s Government Contracting Law Report

      First circuit adds to circuit split over governments dismissal of False Claims Act litigation

      Government Investigations & White-Collar Defense partners Hannah Bornstein and Brian French, of the Boston office, and Adam Tarosky, of the Washington, DC office, co-authored this article covering a circuit court ruling that offers a new standard of review for the government’s dismissal of False Claims Act whistleblower claims.
      June 10, 2022
    • Massachusetts Lawyers Weekly

      Go-to lawyers: Healthcare/life sciences

      Boston partner Hannah Bornstein, deputy leader of the Government Investigations & White-Collar Defense group, was named by the publication as one of Massachusetts’ go-to lawyers for healthcare and life sciences clients. Hannah’s profile provides background details on her practice, noting that she “counsels life sciences companies through a wide range of FDA compliance, enforcement, and litigation matters.”
      May 30, 2022
    • Medtech Insight

      Attorneys mull takeaways from conviction of Theranos founder Holmes

      Boston partner Hannah Bornstein, deputy leader of the Government Investigations & White-Collar Defense practice group, is quoted extensively throughout this article exploring takeaways from the trial and conviction of Theranos founder and former CEO Elizabeth Holmes.
      Jan 6, 2022
    • Law360

      J&J hip implant FCA case tossed over secret info use

      This article covers a significant litigation win, in which a federal judge dismissed a nearly decade-long False Claims Act lawsuit against Johnson & Johnson entities over allegedly defective hip replacement devices, noting that two whistleblower physicians used confidential information in their complaint. The article mentions Boston partners Mark Seltzer and Hannah Bornstein and associate Colin Missett, and Washington, DC partner Adam Tarosky—all of the Government Investigations & White-Collar Defense group—for representing J&J and its related entities.
      Dec 8, 2021
    • The Wall Street Journal

      Elizabeth Holmes's trial reaches turning point: Will she testify?

      This article, focusing on Theranos Inc. founder and CEO Elizabeth Holmes’s trial for allegedly defrauding patients and investors about the capabilities of her blood-testing startup, quotes Boston partner and Government Investigations & White-Collar Defense deputy leader Hannah Bornstein on the risks of putting Holmes on the stand and the possible strategy behind lengthy defense cross-examinations.
      Nov 19, 2021
    • Food Business News

      Regulatory and taste issues slow CBD formulation efforts

      Government Investigations & White-Collar Defense deputy practice group leader and Boston partner Hannah Bornstein is quoted in this article on cannabidiol in food and beverage products for her outlook on therapeutic and marketing claims made by F&B manufacturers as areas of concern for the Food and Drug Administration.
      March 16, 2021
    • Law360

      Doctors say no secret info used in FCA suit against J&J

      This article mentions Boston Government Investigations and White-Collar Defense partners Hannah Bornstein and Mark Seltzer for their representation of the defendants in a False Claims Act suit centering on faulty hip replacement devices. The defendants have argued the suit should be dismissed on the grounds that confidential information was used in the complaint.
      March 6, 2020
    • Modern Healthcare

      21st Century Cures Act driving FDA changes

      This article discussing the 21st Century Cures Act’s ongoing impact on the Food and Drug Administration’s approval process quotes Boston Government Investigations and White Collar Defense partner Hannah Bornstein and Chicago Health Care partner Valerie Montague.
      Sep 7, 2019
    • Law360

      Attorneys reflect on Escobar's FCA impact 2 years later

      Boston government investigations and white collar defense partner Hannah Bornstein is quoted in this article discussing how the Supreme Court’s ruling in Universal Health Services v. Escobar has impacted False Claims Act litigation.
      June 18, 2018
    • Law360

      Law360 names attorneys who moved up the firm ranks in Q1

      In this roundup of promotions to partner and firm management positions, 14 attorneys from Nixon Peabody are highlighted. The 11 attorneys promoted to partner are Ellie Altshuler, Mark Beaudoin, Erik Birkeneder, Hannah Bornstein, Chris Browning, Barry Carrigan, Keri McWilliams, Matt Mullen, Steven Richard, Charles Tamuleviz and Alison Torbitt. In addition, Kenneth C. Lind was promoted to leader of the firms’ public finance practice group, Justin Thompson was promoted to office managing partner in LA, and Aaron Yowell was promoted to chief innovation officer.

      May 7, 2018
    • Law360

      J&J won't get high court look at FCA 'particularity' rule

      In the following coverage, Boston government investigations and white-collar defense partners Mark Seltzer and Hannah Bornstein are mentioned for their ongoing representation of Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc. in a False Claims Act case. The Supreme Court recently declined to review the First Circuit’s ruling in the case.
      April 16, 2018
    • Reuters Legal

      U.S. Supreme Court declines to review whistleblower case against J&J's DePuy

      In the following coverage, Boston government investigations and white-collar defense partners Mark Seltzer and Hannah Bornstein are mentioned for their ongoing representation of Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc. in a False Claims Act case. The Supreme Court recently declined to review the First Circuit’s ruling in the case.
      April 16, 2018
    • Law360

      J&J unit wants whistleblower docs in hip implant FCA suit

      Boston government investigations and white-collar defense partners Mark Seltzer and Hannah Bornstein are mentioned in this article for representing Johnson & Johnson Services Inc. and its subsidiary DePuy Orthopaedics in a suit alleging violations of the False Claims Act.
      April 12, 2018
    • BBA Week

      What do you love about the Boston Marathon?

      Boston government investigations and white collar defense associate Hannah Bornstein is quoted in this column asking attorneys what they like best about the Boston Marathon.
      April 13, 2017
    • Law360

      J&J asks 1st Circ. to halt hip implant FCA suit

      Boston government investigations and white collar defense partners Mark Seltzer and Danielle Pelot and associate Hannah Bornstein are listed as counsel representing Johnson & Johnson and its subsidiary DePuy in a First Circuit case. This article notes their argument to uphold the dismissal of a False Claims Act lawsuit.
      Dec 6, 2016
    • BBA Week

      Beyond the billable: Pro bono spotlight: Nixon Peabody associates volunteer with PAIR project

      This piece profiles Nixon Peabody’s pro bono work and highlights Boston Government Investigations & White Collar Defense associate Hannah Bornstein and IP Litigation associate Troy Lieberman’s involvement with the Political Asylum/Immigration Representation (PAIR) project and why they’re both passionate about it.
      Oct 13, 2016
    • Westlaw Journal Government Contract

      Groundbreaking False Claims Act Decision: Unanimous Supreme Court Upholds ‘Implied False Certification' Theory Under Certain Circumstances

      This column discussing an important United States Supreme Court decision regarding False Claims Act liability was co-authored by Boston partners Brian French and Fred Kelly, Boston associates Hannah Bornstein and Sydney Pritchett, and Washington, DC, associate Emily Harlan.
      July 18, 2016
    • Boston Business Journal

      People on the Move

      This news brief notes that Boston Government Investigations & White Collar Defense associate Hannah Bornstein earned the 2014 Outstanding Pro Bono Mentor Award from the Political Asylum/Immigration Representation Project (PAIR) for her pro bono commitment to representing asylum-seekers.
      June 12, 2014

    Admitted to practice

    Massachusetts

    Education

    Brandeis University, B.A., cum laude
    Indiana University, J.D., magna cum laude

    Professional activities

    Hannah currently serves on FDLI’s Enforcement, Litigation, and Compliance Conference Planning Committee, a position she has held since 2018.

    Hannah is a member of the Boston Bar Association and formerly co-chaired its Immigration Asylum Committee.

    Recognition

    • Selected, through a peer-review survey, for inclusion in The Best Lawyers in America® in the field of Criminal Defense: White-Collar (2023)
    • Recommended in The Legal 500 United States 2022 editorial for practice focus—Dispute resolution - Corporate investigations and white-collar criminal defense
    • Received the Lawyers’ Committee for Civil Rights and Economic Justice pro bono award for commitment to public service (2015)
    • Received the Outstanding Pro Bono Mentor Award from the Political Asylum/Immigration Representation Project (2014)

    Pro bono services

    Hannah has significant experience representing pro bono asylum clients. She has represented clients from Cameroon, Rwanda, Uganda, Nepal, Syria and the Dominican Republic in matters before the Boston Asylum Office and the Boston Immigration Court. Hannah was also a volunteer attorney for the Clemency Project 2014 initiative.

    Hannah is also a three-time Boston Marathon finisher, having successfully completed the 2016, 2017, and 2018 Boston Marathons on behalf of the Political Asylum/Immigration Representation Project.

    Insights And Happenings

    View All
    • Alert

      The rise and fall of Elizabeth Holmes and Theranos: Lessons learned

      Nov 18, 2022
    • Press Release

      Nixon Peabody advises safety technology company in acquisition of medical device manufacturer

      Oct 14, 2022
    • Alert

      Key considerations for telehealth providers following the Dobbs decision

      July 22, 2022
    View All

    Professionals in the Practice Area

    View All
    • Robert Fisher

      Partner / Practice Group Leader, Government Investigations & White Collar Defense
      • Boston
      • Office:617.345.1335
      • rfisher@nixonpeabody.com
      Robert Fisher
    • Brian T. Kelly

      Partner
      • Boston
      • Office:617.345.1065
      • bkelly@nixonpeabody.com
      Brian T. Kelly
    • John Sandweg

      Partner
      • Washington DC
      • Office:202.585.8189
      • jsandweg@nixonpeabody.com
      John Sandweg
    • David A. Vicinanzo

      Partner
      • Boston
      • Office:617.345.1177
      • dvicinanzo@nixonpeabody.com
      David A. Vicinanzo
    • Christopher P. Hotaling

      Partner
      • Chicago
      • Office:312.977.4418
      • chotaling@nixonpeabody.com
      Christopher P. Hotaling
    View All

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL